News Focus
News Focus
icon url

drkazmd65

01/07/15 7:54 PM

#106633 RE: bloomvest #106626

That's kind of sadly amusing IMO,....

You cant buy and buildout an 18,000 sf building with lab space for only $4 million. To me it looks like NNVC paid millions of $$$ for construction work done in The Diwan's building.



How many 18K square foot lab buildings have you had modified (not built from scratch) under your personal supervision?

Can say I have personally participated in a couple of lab-space renovations and upgrades over the years (planning and modifying - not contracting),.... And depending on what was done to the "bricks and mortar" and what upgrades into the water, power and air handling systems needed to be made,...

That's not unreasonable actually.
icon url

KMBJN

01/07/15 10:19 PM

#106637 RE: bloomvest #106626

Don't be disgusted. Read the 8-K and think about it.

"NNVC had likely sunk $11M into a property ..."

No, NNVC states they have $5.15M invested for renovations, after announcing the intention and initial agreement to buy the property.

That, plus the new $4.22M, and the total cost to NNVC is $9.4M, for a property appraised with a replacement value of $15M.

All that complaining by some that Diwan would walk away with a hefty profit - NOT SO. He made $0 profit on the deal (although I imagine they included the interest paid on their presumed mortgage costs?). Good to see.

It is true Diwan cashed out some of his shares for the initial financing (when NNVC had few/poor other choices), which he has now recouped in cash, for what, around $1M from what I recall. He also came up with other investors and his own money from other sources to foot the remaining $3M+ bill, as a low-rate loan to NNVC.

The criticism still also comes up that Diwan "sold out" shareholders by selling shares into the market years ago, but at least there was no dilution to shareholders at that time. It was kind of a pick your poison moment (dilute to raise funds, or sell holdings to raise funds), and management tried to make the more shareholder friendly decision.


All-in-all, it's nice to own a brand new cGMP factory with the possibility of delivering upwards of $2B+ in sales of FluCide per year in the future, for a cost of <$10M. Can they afford it now? I guess this lightens the piggy bank down from $46M do ~$40M, but I can't remember all the numbers. The deal closed 12/30/14, so the cash remaining should show up on the next 10Q.

Now, let's get OUR new factory up to production quickly! Let's get everything validated and certified, let's get those new hires working hard, let's get the scale-up going higher, and let's get a move-on! as we patiently wait :)